FDA authorizes second COVID vaccine booster shot for people 50 and older
The U.S. Food and Drug Administration said Tuesday it has authorized a second booster dose of either the Pfizer/BioNTech PFE, +0.89% BNTX, +3.87% or Moderna MRNA, +3.50% COVID-19 vaccines for people aged 50 and older.
The agency has also authorized a second booster for people aged 12 and older who are immunocompromised and at risk of developing severe illness. The second shot will be administered at least four months after receiving the first booster jab of any authorized or approved COVID vaccine."Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns," the FDA said in a statement.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
The FDA is expected to approve a second COVID booster for people 50 and upThe FDA will likely authorize a secondary booster dose for adults 50 years and older this week.
続きを読む »
FDA Authorizes Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and OlderThe FDA made the decision comes without consulting its committee of independent vaccine experts.
続きを読む »
FDA OKs second Pfizer, Moderna COVID-19 booster for ages 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
続きを読む »
FDA OKs another Pfizer, Moderna COVID booster for 50 and upU.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
続きを読む »